Prognostic indicators in WHO 2003 low‐grade endometrial stromal sarcoma
- 21 February 2013
- journal article
- Published by Wiley in Histopathology
- Vol. 62 (5), 675-687
- https://doi.org/10.1111/j.1365-2559.2011.04115.x
Abstract
Endometrial stromal sarcoma (ESS) has traditionally been divided into low and high grade, but the World Health Organization (WHO, 2003) has changed the definition. Since 2003, many studies have used the old criteria, and few have focused on WHO 2003-defined ESS low grade (ESS-LG). The aim of this study was to investigate prognosticators in ESS-LG. We reviewed the WHO 2003 diagnostic criteria in 91 tumours (previously classified as ESS low and high grade). There were 68 cases of ESS-LG and 23 of undifferentiated endometrial sarcoma (UES). In the ESS-LG cases, the prognostic value of clinicopathological variables was studied. With a median follow-up of 79 months (range: 20-474 months), the recurrence and death rates were 5/68 (7%) and 1/68 (1.5%) in the ESS-LG cases. Ovarian preservation or no ovarian preservation (P < 0.0001, hazard ratio (HR) 10.4) and mitotic activity index (MAI) (0-3 versus >3, P = 0.005, HR 8.6) had independent prognostic value. Other frequently used MAI thresholds - age, tumour diameter, and vessel invasion - were not prognostic. Among patients without ovarian preservation (n = 61), none of 53 with MAI 0-3 suffered recurrence, contrasting with two of eight (25%) of those with MAI >3 (P = 0.003); one of these two recurrence patients died (P = 0.02). Among patients with ovarian preservation (n = 7), three (43%) suffered recurrence but none died, and MAI had no additional prognostic value. In ESS-LG, ovarian preservation and MAI >3 are associated with increased risk of recurrence.Keywords
This publication has 39 references indexed in Scilit:
- Clinicopathologic analysis of uterine sarcomas from a single institution in the Canary IslandsInternational Journal of Gynecology & Obstetrics, 2009
- Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patientsHistopathology, 2009
- Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: Experience in Helsinki University Central Hospital 1990–2001Gynecologic Oncology, 2008
- Prognostic factors and treatment outcomes of patients with uterine sarcoma: analysis of 127 patients at a single institution, 1989–2007Zeitschrift für Krebsforschung und Klinische Onkologie, 2008
- Retrospective analysis of 105 cases with uterine sarcoma.Bulletin du Cancer, 2008
- Prognostic factors and outcome in women with uterine sarcomaEuropean Journal of Surgical Oncology, 2007
- Transition of endometrial stromal sarcoma into high-grade sarcomaGynecologic Oncology, 2006
- Clinical outcomes of uterine sarcomas: results from 14 years worth of experience in the Kinki district in Japan (1990-2003)International Journal of Gynecologic Cancer, 2006
- Uterine sarcoma: twenty-seven years of experienceInternational Journal of Radiation Oncology*Biology*Physics, 2003
- Mesenchymal tumors of the uterus. I. A clinical and pathological study of 53 endometrial stromal tumorsCancer, 1966